APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasminogen

Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.

Selected research

Market Outlook & Growth Opportunities

Global Plasminogen Market Outlook and Growth Opportunities 2026

1 January 2026193 pages

Choose your research edition.

Industry ResearchPlasminogen Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasminogen Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Plasminogen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasminogen Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasminogen Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.

Global Plasminogen key players include Kedrion, Prometic, Genentech (Roche), Boehringer Ingelheim, Kyowa Hakko Kirin, etc. North America is the largest market, with a share about 45%, followed by Europe, with a share about 20 percent. In terms of product, Eye Drops is the largest segment, with a share about 88%.

This report provides an overview of the global Plasminogen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Plasminogen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasminogen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plasminogen market size, projected growth trends, production technologies, key applications, and end-use industries.

Plasminogen Segment by Company

Kedrion

Prometic

Genentech (Roche)

Boehringer Ingelheim

Kyowa Hakko Kirin

Omeros Corporation

Plasminogen Segment by Type

Intravenous Injection

Eye Drops

Plasminogen Segment by Application

Ligneous Conjunctivitis

Diabetic Foot

Wound Healing

Others

Plasminogen Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plasminogen status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Plasminogen market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plasminogen significant trends, drivers, influence factors in global and regions.

6. To analyze Plasminogen competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasminogen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasminogen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasminogen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plasminogen market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasminogen industry.

Chapter 3: Detailed analysis of Plasminogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Plasminogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Plasminogen in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plasminogen Industry Trends Table 2. Plasminogen Industry Drivers Table 3. Plasminogen Industry Opportunities and Challenges Table 4. Plasminogen Industry Restraints Table 5. Global Plasminogen Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plasminogen Revenue Share by Company (2021-2026) Table 7. Global Plasminogen Sales Volume by Company (MT) & (2021-2026) Table 8. Global Plasminogen Sales Volume Share by Company (2021-2026) Table 9. Global Plasminogen Average Price (USD/MT) of Company (2021-2026) Table 10. Global Plasminogen Company Ranking, (2024-2026) & (USD Million) Table 11. Global Plasminogen Key Company Manufacturing Base & Headquarters Table 12. Global Plasminogen Company, Product Type & Application Table 13. Global Plasminogen Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Plasminogen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Intravenous Injection Table 18. Significant Companies of Eye Drops Table 19. Global Plasminogen Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global Plasminogen Sales Volume by Type (2021-2026) & (MT) Table 21. Global Plasminogen Sales Volume by Type (2027-2032) & (MT) Table 22. Global Plasminogen Sales Volume Share by Type (2021-2026) Table 23. Global Plasminogen Sales Volume Share by Type (2027-2032) Table 24. Global Plasminogen Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Plasminogen Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Plasminogen Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Plasminogen Sales Value Share by Type (2021-2026) Table 28. Global Plasminogen Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Ligneous Conjunctivitis Table 30. Significant Companies of Diabetic Foot Table 31. Significant Companies of Wound Healing Table 32. Significant Companies of Others Table 33. Global Plasminogen Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 34. Global Plasminogen Sales Volume by Application (2021-2026) & (MT) Table 35. Global Plasminogen Sales Volume by Application (2027-2032) & (MT) Table 36. Global Plasminogen Sales Volume Share by Application (2021-2026) Table 37. Global Plasminogen Sales Volume Share by Application (2027-2032) Table 38. Global Plasminogen Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Plasminogen Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Plasminogen Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Plasminogen Sales Value Share by Application (2021-2026) Table 42. Global Plasminogen Sales Value Share by Application (2027-2032) Table 43. Global Plasminogen Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 44. Global Plasminogen Sales by Region (2021-2026) & (MT) Table 45. Global Plasminogen Sales Market Share by Region (2021-2026) Table 46. Global Plasminogen Sales by Region (2027-2032) & (MT) Table 47. Global Plasminogen Sales Market Share by Region (2027-2032) Table 48. Global Plasminogen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Plasminogen Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Plasminogen Sales Value Share by Region (2021-2026) Table 51. Global Plasminogen Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Plasminogen Sales Value Share by Region (2027-2032) Table 53. Global Plasminogen Market Average Price (USD/MT) by Region (2021-2026) Table 54. Global Plasminogen Market Average Price (USD/MT) by Region (2027-2032) Table 55. Global Plasminogen Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 56. Global Plasminogen Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Plasminogen Sales by Country (2021-2026) & (MT) Table 58. Global Plasminogen Sales Market Share by Country (2021-2026) Table 59. Global Plasminogen Sales by Country (2027-2032) & (MT) Table 60. Global Plasminogen Sales Market Share by Country (2027-2032) Table 61. Global Plasminogen Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Plasminogen Sales Value Market Share by Country (2021-2026) Table 63. Global Plasminogen Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Plasminogen Sales Value Market Share by Country (2027-2032) Table 65. Kedrion Company Information Table 66. Kedrion Business Overview Table 67. Kedrion Plasminogen Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 68. Kedrion Plasminogen Product Portfolio Table 69. Kedrion Recent Development Table 70. Prometic Company Information Table 71. Prometic Business Overview Table 72. Prometic Plasminogen Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 73. Prometic Plasminogen Product Portfolio Table 74. Prometic Recent Development Table 75. Genentech (Roche) Company Information Table 76. Genentech (Roche) Business Overview Table 77. Genentech (Roche) Plasminogen Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 78. Genentech (Roche) Plasminogen Product Portfolio Table 79. Genentech (Roche) Recent Development Table 80. Boehringer Ingelheim Company Information Table 81. Boehringer Ingelheim Business Overview Table 82. Boehringer Ingelheim Plasminogen Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 83. Boehringer Ingelheim Plasminogen Product Portfolio Table 84. Boehringer Ingelheim Recent Development Table 85. Kyowa Hakko Kirin Company Information Table 86. Kyowa Hakko Kirin Business Overview Table 87. Kyowa Hakko Kirin Plasminogen Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 88. Kyowa Hakko Kirin Plasminogen Product Portfolio Table 89. Kyowa Hakko Kirin Recent Development Table 90. Omeros Corporation Company Information Table 91. Omeros Corporation Business Overview Table 92. Omeros Corporation Plasminogen Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 93. Omeros Corporation Plasminogen Product Portfolio Table 94. Omeros Corporation Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Plasminogen Distributors List Table 98. Plasminogen Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Plasminogen Product Image Figure 2. Global Plasminogen Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasminogen Sales Value (2021-2032) & (US$ Million) Figure 4. Global Plasminogen Sales (2021-2032) & (MT) Figure 5. Global Plasminogen Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global Plasminogen Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Intravenous Injection Image Figure 10. Eye Drops Image Figure 11. Global Plasminogen Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Plasminogen Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Plasminogen Sales Volume Share by Type (2021-2032) Figure 14. Global Plasminogen Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Plasminogen Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Plasminogen Sales Value Share by Type (2021-2032) Figure 17. Ligneous Conjunctivitis Image Figure 18. Diabetic Foot Image Figure 19. Wound Healing Image Figure 20. Others Image Figure 21. Global Plasminogen Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 22. Global Plasminogen Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Plasminogen Sales Volume Share by Application (2021-2032) Figure 24. Global Plasminogen Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Plasminogen Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Plasminogen Sales Value Share by Application (2021-2032) Figure 27. Global Plasminogen Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 28. Global Plasminogen Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Plasminogen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Plasminogen Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Plasminogen Sales Value (2021-2032) & (US$ Million) Figure 32. North America Plasminogen Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Plasminogen Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Plasminogen Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Plasminogen Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Plasminogen Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Plasminogen Sales Value (2021-2032) & (US$ Million) Figure 38. South America Plasminogen Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Plasminogen Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Plasminogen Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Plasminogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Plasminogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Plasminogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Plasminogen Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Plasminogen Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Injection
  • Eye Drops
Applications
  • Ligneous Conjunctivitis
  • Diabetic Foot
  • Wound Healing
  • Others
Companies covered
  • Kedrion
  • Prometic
  • Genentech (Roche)
  • Boehringer Ingelheim
  • Kyowa Hakko Kirin
  • Omeros Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plasminogen Sales Value (2021-2032)
  4. 1.2.2 Global Plasminogen Sales Volume (2021-2032)
  5. 1.2.3 Global Plasminogen Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Plasminogen Market Dynamics
  1. 2.1 Plasminogen Industry Trends
  2. 2.2 Plasminogen Industry Drivers
  3. 2.3 Plasminogen Industry Opportunities and Challenges
  4. 2.4 Plasminogen Industry Restraints
3 Plasminogen Market by Company
  1. 3.1 Global Plasminogen Company Revenue Ranking in 2025
  2. 3.2 Global Plasminogen Revenue by Company (2021-2026)
  3. 3.3 Global Plasminogen Sales Volume by Company (2021-2026)
  4. 3.4 Global Plasminogen Average Price by Company (2021-2026)
  5. 3.5 Global Plasminogen Company Ranking (2024-2026)
  6. 3.6 Global Plasminogen Company Manufacturing Base and Headquarters
  7. 3.7 Global Plasminogen Company Product Type and Application
  8. 3.8 Global Plasminogen Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Plasminogen Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Plasminogen Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Plasminogen Market by Type
  1. 4.1 Plasminogen Type Introduction
  2. 4.1.1 Intravenous Injection
  3. 4.1.2 Eye Drops
  4. 4.2 Global Plasminogen Sales Volume by Type
  5. 4.2.1 Global Plasminogen Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Plasminogen Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Plasminogen Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Plasminogen Sales Value by Type
  9. 4.3.1 Global Plasminogen Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Plasminogen Sales Value by Type (2021-2032)
  11. 4.3.3 Global Plasminogen Sales Value Share by Type (2021-2032)
5 Plasminogen Market by Application
  1. 5.1 Plasminogen Application Introduction
  2. 5.1.1 Ligneous Conjunctivitis
  3. 5.1.2 Diabetic Foot
  4. 5.1.3 Wound Healing
  5. 5.1.4 Others
  6. 5.2 Global Plasminogen Sales Volume by Application
  7. 5.2.1 Global Plasminogen Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Plasminogen Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Plasminogen Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Plasminogen Sales Value by Application
  11. 5.3.1 Global Plasminogen Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Plasminogen Sales Value by Application (2021-2032)
  13. 5.3.3 Global Plasminogen Sales Value Share by Application (2021-2032)
6 Plasminogen Regional Sales and Value Analysis
  1. 6.1 Global Plasminogen Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasminogen Sales by Region (2021-2032)
  3. 6.2.1 Global Plasminogen Sales by Region: 2021-2026
  4. 6.2.2 Global Plasminogen Sales by Region (2027-2032)
  5. 6.3 Global Plasminogen Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Plasminogen Sales Value by Region (2021-2032)
  7. 6.4.1 Global Plasminogen Sales Value by Region: 2021-2026
  8. 6.4.2 Global Plasminogen Sales Value by Region (2027-2032)
  9. 6.5 Global Plasminogen Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Plasminogen Sales Value (2021-2032)
  12. 6.6.2 North America Plasminogen Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Plasminogen Sales Value (2021-2032)
  15. 6.7.2 Europe Plasminogen Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Plasminogen Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Plasminogen Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Plasminogen Sales Value (2021-2032)
  21. 6.9.2 South America Plasminogen Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Plasminogen Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Plasminogen Sales Value Share by Country, 2025 VS 2032
7 Plasminogen Country-level Sales and Value Analysis
  1. 7.1 Global Plasminogen Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plasminogen Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Plasminogen Sales by Country (2021-2032)
  4. 7.3.1 Global Plasminogen Sales by Country (2021-2026)
  5. 7.3.2 Global Plasminogen Sales by Country (2027-2032)
  6. 7.4 Global Plasminogen Sales Value by Country (2021-2032)
  7. 7.4.1 Global Plasminogen Sales Value by Country (2021-2026)
  8. 7.4.2 Global Plasminogen Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Plasminogen Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Plasminogen Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Plasminogen Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Plasminogen Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Plasminogen Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Plasminogen Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Plasminogen Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Plasminogen Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Plasminogen Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Plasminogen Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Plasminogen Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Plasminogen Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Plasminogen Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Plasminogen Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Plasminogen Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Plasminogen Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Plasminogen Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Plasminogen Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Plasminogen Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Plasminogen Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Plasminogen Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Plasminogen Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Plasminogen Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Plasminogen Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Plasminogen Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Plasminogen Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Plasminogen Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Plasminogen Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Plasminogen Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Plasminogen Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Plasminogen Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Plasminogen Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Plasminogen Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Plasminogen Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Plasminogen Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Plasminogen Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Plasminogen Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Plasminogen Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Plasminogen Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Plasminogen Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Plasminogen Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Plasminogen Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Plasminogen Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Plasminogen Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Plasminogen Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Plasminogen Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Plasminogen Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Plasminogen Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Plasminogen Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Plasminogen Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Plasminogen Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Plasminogen Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Plasminogen Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Plasminogen Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Plasminogen Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Plasminogen Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Plasminogen Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Plasminogen Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Plasminogen Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Plasminogen Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Plasminogen Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Plasminogen Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Plasminogen Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Plasminogen Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Plasminogen Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Plasminogen Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Plasminogen Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Plasminogen Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Plasminogen Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Plasminogen Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Plasminogen Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Plasminogen Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Plasminogen Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Plasminogen Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Plasminogen Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Plasminogen Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Plasminogen Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Plasminogen Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Plasminogen Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Plasminogen Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Plasminogen Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Plasminogen Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Plasminogen Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Plasminogen Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kedrion
  2. 8.1.1 Kedrion Company Information
  3. 8.1.2 Kedrion Business Overview
  4. 8.1.3 Kedrion Plasminogen Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Kedrion Plasminogen Product Portfolio
  6. 8.1.5 Kedrion Recent Developments
  7. 8.2 Prometic
  8. 8.2.1 Prometic Company Information
  9. 8.2.2 Prometic Business Overview
  10. 8.2.3 Prometic Plasminogen Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Prometic Plasminogen Product Portfolio
  12. 8.2.5 Prometic Recent Developments
  13. 8.3 Genentech (Roche)
  14. 8.3.1 Genentech (Roche) Company Information
  15. 8.3.2 Genentech (Roche) Business Overview
  16. 8.3.3 Genentech (Roche) Plasminogen Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Genentech (Roche) Plasminogen Product Portfolio
  18. 8.3.5 Genentech (Roche) Recent Developments
  19. 8.4 Boehringer Ingelheim
  20. 8.4.1 Boehringer Ingelheim Company Information
  21. 8.4.2 Boehringer Ingelheim Business Overview
  22. 8.4.3 Boehringer Ingelheim Plasminogen Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Boehringer Ingelheim Plasminogen Product Portfolio
  24. 8.4.5 Boehringer Ingelheim Recent Developments
  25. 8.5 Kyowa Hakko Kirin
  26. 8.5.1 Kyowa Hakko Kirin Company Information
  27. 8.5.2 Kyowa Hakko Kirin Business Overview
  28. 8.5.3 Kyowa Hakko Kirin Plasminogen Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kyowa Hakko Kirin Plasminogen Product Portfolio
  30. 8.5.5 Kyowa Hakko Kirin Recent Developments
  31. 8.6 Omeros Corporation
  32. 8.6.1 Omeros Corporation Company Information
  33. 8.6.2 Omeros Corporation Business Overview
  34. 8.6.3 Omeros Corporation Plasminogen Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Omeros Corporation Plasminogen Product Portfolio
  36. 8.6.5 Omeros Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plasminogen Value Chain Analysis
  2. 9.1.1 Plasminogen Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plasminogen Sales Mode & Process
  6. 9.2 Plasminogen Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plasminogen Distributors
  9. 9.2.3 Plasminogen Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst